![]() | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
| "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2017-12-01 Sale | 2017-12-05 4:18 pm | ALBIREO PHARMA Inc | ALBO | ASTRAZENECA PLC ASTRAZENECA AB 10% Owner | 500,000 | $21.4 | $10,700,000 | 508,141 (Indirect) | View |
2018-09-28 Purchase | 2018-10-02 9:35 pm | Entasis Therapeutics Holdings Inc. | ETTX | ASTRAZENECA PLC ASTRAZENECA AB 10% Owner | 246,666 | $15 | $3,699,990 | 2,164,855 (Indirect) | View |
2018-10-22 Purchase | 2018-10-24 4:16 pm | PhaseBio Pharmaceuticals Inc | PHAS | ASTRAZENECA PLC Zeneca Inc. 10% Owner | 600,000 | $5 | $3,000,000 | 3,004,554 (Indirect) | View |
2019-10-07 Purchase | 2019-10-09 4:53 pm | Viela Bio Inc. | VIE | ASTRAZENECA PLC AstraZeneca UK LTD 10% Owner | 425,000 | $19 | $8,075,000 | 14,650,334 (Indirect) | View |
2019-12-19 Purchase | 2020-02-07 12:58 pm | Aevi Genomic Medicine Inc. | GNMX | ASTRAZENECA PLC MedImmune Ltd 10% Owner | 12,946,900 | $0 | $0 | 12,946,900 (Indirect) | View |
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2018-09-28 Conversion | 2018-10-02 9:35 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | ASTRAZENECA PLC ASTRAZENECA AB 10% Owner | 1,918,185 | $0 | 2,164,855 (Indirect) | View |
2018-09-28 Conversion | 2018-10-02 9:35 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | ASTRAZENECA PLC ASTRAZENECA AB 10% Owner | 33,499,900 | $0 | 2,164,855 (Indirect) | View |
2018-10-22 Conversion | 2018-10-24 4:16 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | ASTRAZENECA PLC Zeneca Inc. 10% Owner | 2,404,554 | $0 | 3,004,554 (Indirect) | View |
2018-10-22 Exercise | 2018-10-24 4:16 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | ASTRAZENECA PLC Zeneca Inc. 10% Owner | 113,891 | $0.12 | 3,004,554 (Indirect) | View |
2018-10-22 Exercise | 2018-10-24 4:16 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | ASTRAZENECA PLC Zeneca Inc. 10% Owner | 113,891 | $0.12 | 3,004,554 (Indirect) | View |
2018-10-22 Sale | 2018-10-24 4:16 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | ASTRAZENECA PLC Zeneca Inc. 10% Owner | 2,734 | $5 | 3,004,554 (Indirect) | View |
2018-10-22 Conversion | 2018-10-24 4:16 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | ASTRAZENECA PLC Zeneca Inc. 10% Owner | 1,664,217 | $0 | 3,004,554 (Indirect) | View |
2018-10-22 Conversion | 2018-10-24 4:16 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | ASTRAZENECA PLC Zeneca Inc. 10% Owner | 740,337 | $0 | 3,004,554 (Indirect) | View |
2019-10-07 Conversion | 2019-10-09 4:53 pm | N/A N/A | Viela Bio Inc. | VIE | ASTRAZENECA PLC AstraZeneca UK LTD 10% Owner | 14,225,324 | $0 | 14,650,334 (Indirect) | View |
2019-10-07 Conversion | 2019-10-09 4:53 pm | N/A N/A | Viela Bio Inc. | VIE | ASTRAZENECA PLC AstraZeneca UK LTD 10% Owner | 14,225,324 | $0 | 14,650,334 (Indirect) | View |